Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Nokia Defense and KNDS close critical connectivity gap for soldiers and unmanned systems
-
Bitdeer Announces May 2026 Production and Operations Update
-
Aurora Mobile and AI Storm Enter into Business Partnership to Advance AI-Powered Customer Operations in Japan
-
Roma Green Finance to Receive Right of First Offer to Provide Project-Level Funding for Up to 500 Megawatts of Distributed Behind-the-Meter Data Centre Capacity in Alberta, Canada
-
Lotus Tech Releases 2025 Sustainability Report, Highlighting Progress Across Governance, Product Innovation, and Value Chain
-
OMS Energy Technologies Inc. to Announce Fiscal Year 2026 Financial Results on Thursday, June 25, 2026
-
Oroco Increases South Zone Certainty at Santo Tomás
-
CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042
-
Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month
-
Ambow Education Holding Ltd. (NYSE American: AMBO) Launches HybriU ProjectHub, an AI-Powered Project Collaboration Platform Unifying Documents, Conversations, and Live Collaboration in a Single Secure
-
Nuvini Launches Second AI Prize, Targeting 100% Employee AI Adoption
-
Hi*Ball Energy Arrives in the UK, Leading a New Wave of Clean Energy
-
Chicago Atlantic Real Estate Finance, Inc. and Chicago Atlantic BDC, Inc. Announce Definitive Merger Agreement
-
Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-304 for the Treatment of Phenylketonuria (PKU) by the United States (U.S.) Food and Drug Administration
-
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
-
VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026
-
Memo Therapeutics AG Presents Complete Phase II Clinical Trial Data for Potravitug in Kidney Transplant Recipients at the American Transplant Congress 2026
-
Formation Metals Extends A-Zone 200 Metres West of Historic Resource into Previously Undrilled Ground, Returning 1.05 g/t Au over 31 Metres at the Advanced N2 Gold Project
-
Essential Pharma appoints Becki Morison as Chief Executive Officer
-
Crypto News: Gruntle Presale Passes $106k as Long-Term Bitcoin Holders Absorb 125,000 BTC and US-Iran Calms
-
Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026
-
A2MAC1 signs Agreement to acquire Tset in order to accelerate next phase of growth in AI-enabled Costing Intelligence
-
Wood Mackenzie: Orbital Data Centres Cost Three Times More Than Terrestrial Alternatives as Global Power Demand Heads for 3,700 TWh
-
Oklo, Centrus Sign Letter of Intent to Purchase Nuclear Fuel for Aurora Powerhouse Deployment in Southern Ohio
-
IASO Bio Announces NDA Approval of Equecabtagene Autoleucel by the Singapore Health Sciences Authority (HSA) for the Treatment of Relapsed or Refractory Multiple Myeloma, Marking a Key Milestone in In
-
IFCO Launches TRLLN, a Pioneering Tracking-as-a-Service Solution for Global Asset Visibility
-
Zoomlion Highlights AI, Green Technology and Global R&D Priorities at Seventh Technology Innovation Conference
-
Life & Banc Split Corp. Announces Class a Share Split and an Increase to Total Distributions
-
Wallbox Launches New Pulsar Pro to Simplify EV Charging Reimbursement
-
Endeavour Silver Intersects High-Grade Silver and Gold Mineralization at its Terronera Operation
-
Brompton Lifeco Split Corp. Announces Class A Share Split and an Increase to Total Distributions
-
T1 Announces Results from 2026 Annual Meeting of Stockholders
-
Hong Kong rises to No.2 globally in competitiveness
-
TORL BioTherapeutics Presents Preliminary Safety and Efficacy Data of Ixotatug Vedotin (TORL-1-23) in Combination with Bevacizumab in Recurrent Ovarian Cancer at ESMO Gynaecological Cancers Congress 2
-
Kroger Reports First Quarter 2026 Results
-
Uxin Announces Management Share Purchase Plan
-
U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
-
Pfizer Announces Chief Financial Officer Transition
-
Lindsay Corporation Announces Third Quarter Fiscal 2026 Earnings Conference Call and Webcast
-
Brookfield to sell Multiplex to Obayashi for $650 million
-
European Equity Research Partners launches issuer-funded analyst coverage across Europe, the Middle East and Central Asia
-
Scorpio Tankers Inc. Announces Update on Second Quarter 2026 TCE Rates
-
As AI Strains the Grid, Envision Launches Mission Gobi at VivaTech 2026
-
Toobit Rewards Prediction Market Traders with 100,000 USDT
-
TheCyGuide.com Announces Launch of New Digital Guide Designed to Help Travelers Discover the Best of Cyprus
-
Alturos Therapeutics advancement of lead candidate ALT0135, a potentially first-in-class, orally bioavailable small molecule, into IND-enabling studies
-
Accenture Reports Third-Quarter Fiscal 2026 Results
-
Zoomex Launches World Cup Prediction Market Campaign: Users Can Predict Matches with Crypto and Unlock Live Match Tickets and Multiple Rewards
-
Fingrid Oyj’s financial releases in 2027
-
Accenture to Strengthen Critical Infrastructure Defense with End-to-End Cybersecurity Platform in Age of AI-Driven Cyber Threats and Geopolitical Risk
